Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-08-21

Clinical Trial Update: A Study of Milvexian Using an IV Microtracer With Additional Formulation and Food Effect Comparison in Healthy Participants [Phase 1]

View source ↗

Summary

Phase 1 study evaluating milvexian with IV microtracer, additional formulation, and food effect in healthy volunteers; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Milvexian (milvexian)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Healthy Volunteers | Phase 1 | Status: COMPLETED | Results posted: 2023-08-21